Scandinavian Real Heart AB
1 Feb - 28 Feb 2023Warrant exercise TO 1
The power of Swedish innovation has provided the world with medtech inventions such as the heart and lung machine, the pace maker and the dialysis machine. The next big innovation is Realheart’s artificial heart. A Swedish patented product that saves lives and provides a better quality of a prolonged life.
Azad Najar outlined the company’s vision in 1999 when he began designing an artificial heart that mimicked the human heart. In 2007, Azad and two business partners founded Scandinavian Real Heart.
The development of the product has advanced according to the time schedule set when the company was founded. Today, research is carried out in a close collaboration with world-leading heart surgeons, international researchers and engineers and interest from the world of research is constantly growing.
The business is run by a strong, competent and engaged team, competent and broad management team, under a strong board of directors.
The offer in summary
Subscription period: 1 Februari - 28 Februari 2023
Price per share: SEK 2.36
Trading with warrants: 1 Februari - 24 Februari 2023
Terms: Four (4) warrants of serie TO 1 gives you the right to subscribe for one (1) new share.
Payment day: 28 Februari 2023
Market place: First North Stockholm
Financial advicer: Skills Corporate Finance